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Background. There is limited information about the association between disability and all-
cause and cause-specific mortality among community-dwelling adults. 
Methods. We used baseline data from 162,381 adults who participated in a countrywide 
disability survey in 2008. A nationally representative sample was selected and interviewed in 
their homes. We present data on people aged 18 or over. Disability was considered as any 
substantial limitation found on a list of 44 life activities that have lasted or are expected to last 
more than 1 year and originate from an impairment. Cause-specific mortality data were 
obtained from the Spanish Statistical Office. Subjects contributed follow-up time from their 
baseline interview until death or the censoring date of 31st December 2017. We computed 
standardized rate ratios, with age, sex, living with a partner, and education level distribution of 
the total group as the standard population.  
Results. Adults with disability (11%) had an adjusted mortality rate more than twice as high as 
adults without disability [standardized rate ratio (SRR) (95% confidence interval): 2.37 (2.24-
2.50)]. A clear higher mortality risk remained over 10-year follow-up. Mortality due to diseases 
of the nervous system [SRR 4.86 (3.93-6.01)], diseases of the musculoskeletal system [SRR 3.45 
(2.18-5.47)], infectious diseases [SRR 3.38 (2.27-5.01)] and diabetes mellitus [SRR 3.56 (2.71-
4.68)] was particularly high in those with disability.  
Conclusions. All-cause mortality rates are markedly higher among adults with disability. 
Preventive measures and health promotion initiatives are needed to reduce mortality risk in 
this population. Special attention should be paid to disabled people with certain specific 
diseases.  









Disability is an umbrella term, covering impairments, activity limitations, and participation 
restrictions. Impairments are problems in body function or structure; an activity limitation is a 
difficulty in executing a task or action; whereas participation restriction refers to problems in 
involvement in life situations.1 
There are many types of disabilities, such as those that affect vision, hearing, movement, 
thinking, remembering, learning, communicating, mental health, and social relationships.2 
Disability, in either of its different types, could appear in relation to very different conditions, 
injuries or diseases.2  
The prevalence of disability is largely heterogeneous because of real differences in the 
prevalence of its determinants but also due to different definitions and sources. It can range 
between 10% and 15% of the population.3 The association between disability and health is also 
complex. Disability can be the consequence of disease or health conditions but also their 
cause, since it has been reported that 87% of people with disability have at least one 
secondary health condition.4 So, different disabilities have been identified as determinants for 
multiple  conditions that are potentially  related to an increased risk of death, such as 
depression,5 decubitus ulcers,5 a reduced immune function,5 pulmonary infections,5 obesity,6,7 
and weight problems in general,4 bowel and bladder problems,4 asthma,4 cardiovascular 
problems,7 anxiety4,7and more propensity to injuries and falls,4 among others. Disabilities can 
also cause difficulty getting out into the community4, sleep problems4 and muscle spasms4 that 
could be related to poorer mental health including higher risk of suicide.5 Moreover, despite 
advances in personalized care, health professionals are not always properly prepared to 
diagnose and treat the secondary conditions derived from disability,5  which can lead to a 
worse prognosis. Thus, it is reasonable to expect that disability may be associated with an 
increased risk of death.  
Many studies show associations between disability and mortality in older populations but 
there are few studies that primarily focus on measuring this association in representative 
samples of adult populations.  
In 2008, the Spanish Statistical Office carried out a large nationwide survey on disability.8 This 
survey formed the baseline cohort for a subsequent follow-up study on mortality.  
The main objective of this research was to measure the association of disability with all-cause 




Baseline data come from the 2008 Spanish Survey on Disabilities, Personal Autonomy and 
Dependency (Encuesta Sobre Discapacidades, Autonomía Personal y Situaciones de 
Dependencia [EDAD2008]).8  
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The study population covered by EDAD2008 consisted of a two-step, stratified, random sample 
of the community-dwelling population, representative of each province: first, a sample of 
census tracts was drawn, and a sample of family dwellings was then randomly selected within 
each tract. Thereafter, all households within the dwelling were group screened, and one 
member of each household was interviewed as the main informant. Subjects identified with a 
possible disability were then interviewed in depth. The interviews were conducted between 
November 2007 and February 2008. A total of 258,187 people living in 91,290 households 
were thus screened for disability. Data on mortality could be obtained for 207,529 subjects 
(80.4%). Of these, 162,381 people aged 18 years or over formed the study sample. Missing 
data on mortality was due to difficulties in identifying subjects. 
The study was approved by the Institute of Health Carlos III Ethics Committee. 
Study variables 
In the EDAD2008 survey disability was considered as any important limitation to carrying out 
an activity, which had lasted or was expected to last more than 1 year and whose origin was an 
impairment. A person was considered to have a disability even if it had been overcome with 
the use of external technical aids, or with the help and/or supervision of another person. For 
screening purposes, a list of 44 questions about possible disabilities – read verbatim – was 
presented to the main informant of each household (see Supplementary material). The list 
addressed the following eight domains: vision; audition; communication; learning and 
application of knowledge and performance of tasks; mobility; self-care; domestic life; 
interaction and interpersonal relationships. People who answered affirmatively to at least one 
of these questions formed the disability group. To assess disability severity, we used two 
methods. First, a reported score based on the International Classification of Functioning 
Disability and Health (ICF) Checklist.9 Twenty nine EDAD2008 items were backcoded to specific 
domains of the ICF Checklist and by rating the recorded difficulty performing specific tasks. A 
global ICF score was derived, albeit lacking data for domains d1, “Learning and applying 
knowledge”, d8, “Major Life Areas” and d9, “Community, Social and Civic Life”. Disability 
severity was categorized into mild, moderate, severe, and complete disability according to ICF 
categories. The categories of severe and complete disability were collapsed together; 
consequently, a 4-category variable was analyzed (no disability; mild; moderate; 
severe/complete). A detailed explanation of these procedures can be found elsewhere.10 As a 
second step, the number of disabilities identified for each person was grouped together to 
produce four categories: 0; 1 to 3; 4 to 9; and 10 to 42.  
Age, marital status and educational level attained were obtained by interview.  
Mortality data was provided by the Spanish Statistical Office (INE). Underlying causes of death 
were coded using the International Statistical Classification of Diseases and Related Health 
Problems, 10th Revision reduced list.11,12 These include 102 different causes of death grouped 
into 17 types. 
Subjects contributed follow-up time from their baseline interview until death or the censoring 




Overall baseline proportions, means and crude rates were weighted with sampling weights. 
These were computed as the inverse of each participant’s baseline selection probability, 
corrected by non-response. 
To estimate the adjusted association of disability with mortality −all-cause and cause-specific− 
we computed standardized rate ratios (SRR) via inverse probability weighting,13 taking the 
baseline distribution of age (18-39; 40-64; 65-74; ≥75 years) , sex (women or men), living with 
a partner (yes or no), and educational level (less than primary; primary; secondary; pre-
university; university) for the total population as the standard. Weights for subjects were 
computed as the inverse of the conditional probability of being in their own exposure 
category, computed through sampling-weighted logistic regression models with disability as 
dependent variable, and the independent variables above as covariates. In the case of the 
four-category disability variables (ICF severity and number of disabilities), these probabilities 
were estimated through multinomial logistic regression models. Weights were then multiplied 
by the unconditional probability of being in their own exposure category. These stabilized 
weights were finally multiplied by the sampling weights. We computed weighted Poisson 
regression models for estimating standardized rates and rate ratios with these final weights, 
with disability as the independent variable and the logarithm of each observed person-year as 
the offset variable. To evaluate time-dependent effects, we computed 10 SRRs with increasing 
follow-up time, from 1 to 10 years. 
Population attributable fraction for disability was calculated with the formula f(SMR−1)/SMR,14 
where f is the fraction with disability among deaths and SMR is the Standardized Mortality 
Ratio. SMR was computed via inverse probability weighting using the baseline distribution of 
the disability group as standard. In this case the weight for the i subject was estimated by 
fitting a sampling-weighted logistic regression model with disability status (E) as dependent 
variable and age, sex, living with a partner and educational level as independent variables (Z), 
and computed as: 
𝑤𝑖 =
𝑃(𝐸 = 1|𝑍 = 𝑧𝑖)
𝑃(𝐸 = 𝑒𝑖|𝑍 = 𝑧𝑖)
 
Thus, weights were 1 for disability subjects, and the conditional disability odds for non-
disability.15 Final weights were the product of sampling weights and standardization weights 
and applied in a Poisson model to obtain the SMR. Confidence intervals for the population 
attributable fraction were calculated with the formula proposed by Greenland.16  
Due to the complex sampling design, we used appropriate methods to account for the effect of 
stratification and clustering on standard errors. Analyses were run with Stata 1517. 
RESULTS 
Baseline characteristics of the study population are shown in Table 1. The prevalence (95% 
confidence interval [CI]) of disability was 11.0% (10.7-11.2%), and was higher in older people, 
women, participants not living with a partner, and those with lower educational levels. 
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There were 17,132 deaths in 1,541,910 person-years follow-up. The median follow-up was 
10.0 years. The sampling weighted mortality rates (95%CI) per 1000 person-years, were 10.0 
(10.1-10.6), for the overall population, 50.8 (49.3-52.3) for the disability group and 6.4 (6.2-
6.6) for the non-disability group, for a crude rate ratio of 7.93 (7.63-8.24).  
Table 2 shows the standardized mortality rates for the whole group and for subgroups of sex 
and age. The standardized rates per 1000 person-years were 20.03 for the disability group and 
8.47 for non-disability group, for a standardized rate ratio (SRR) of 2.37. The standardized rate 
difference (SRD) between the mortality of the disability group and the non-disability group was 
11.56 per 1000 person-years. There was little difference in the relative estimates by sex, with 
SRR of 2.37 for women and 2.38 for men. There was a clear gradient by age with younger 
people showing higher SRRs and older groups with notably higher SRDs.  
The SMR (95% CI) was 1.92 (1.83-1.99) and the fraction of persons with disability among the 
deceased was 0.44, for a population attributable fraction (95% CI) of 0.21 (0.20-0.22). 
Supplementary Figures 1 and 2 show the estimates for increasing follow-up years. The SRRs 
were very high in the first years of follow-up but remained high and over 2 throughout the 10 
years. SRDs were also declined with follow-up time. 
Tables 3 and 4 show the association of disability severity with mortality, measured both by the 
ICF score and the number of disabilities suffered by each subject. In both cases a strong 
gradient was evident. 
Table 5 shows the cause-specific mortality associated with disability. Disability was clearly 
associated with mortality in all groups. The SRR was particularly high in the following groups: 
diseases of the nervous system (4.86), diseases of the musculoskeletal system (3.45), 
infectious diseases (3.38), diseases of the genitourinary system (3.10), and endocrine diseases 
(3.08); and was lower for neoplasms (1.74). In terms of absolute impact, as measured by the 
SRD, diseases of the circulatory system and neoplasms showed higher figures, with 3.24 and 
2.13 deaths per 1000 person years, respectively. 
The association between disability and more specific causes of death can be found in 
Supplementary Table 1. Some of these estimates are unstable due to small number of cases 
(for a simple measure of precision for rate ratio estimates, we provide the ratio of the upper to 
lower confidence limits; as a somewhat arbitrary guide, estimates with ratios below 2 are 
deemed very precise and above 10 are very unstable). Based on reasonable stable estimates 
and strength of association some causes (code12) deserve particular attention: Septicemia 
(004);  Alzheimer's disease (051);  Other diseases of blood vessels (061); Malignant tumor of 
the breast (023); Cardiac arrest, unassisted death and other unknown cause of mortality (086); 
Intestinal vascular disease (070); Diseases of the kidney and ureter (077); Other accidents 
(097); Accidental drowning, submersion and suffocation (093); Diabetes mellitus (044); Suicide 
and self-inflicted injuries (098); Malignant tumor of the brain (033); Other diseases of the 
musculoskeletal system and connective tissue (076); Malignant tumor of the larynx (017); 





In this large follow-up study, we found mortality to be more than 100% higher in persons with 
disability, with a population attributable fraction of 21%. This could be translated to a figure of 
87,309 annual deaths attributable to disability in the Spanish adult population (415,757 total 
deaths in people aged ≥18 years, estimated for 2019).18 We also found that the risk remains 
high over time. Interestingly, we found a clear increase in risk for almost all of causes of death. 
A limited number of works have primarily measured mortality associated with disability in 
representative samples. In general, the estimates presented by these studies are similar to 
those of the present article. Majer et al an found 65% higher mortality in the Dutch population 
over 55 years of age (average adjusted hazard ratio=1.65).19 Forman-Hoffman et al report a 
50% higher risk of mortality in people with disabilities, in a representative study of the 
American population aged 18 or over.20 Wu et al report an adjusted hazard ratio of 2.23 in a 
follow-up study of a representative sample of American older people.21 Finally, Park et al found 
57% higher adjusted mortality in the disabled group in a large all-age Korean population.22  
The study of mortality associated with disability is complex due to the nature of the 
determinants of disability and its consequences. These determinants are both numerous and 
varied and the causal paths equally intricate.3,23 Some diseases lead to disability but are also 
associated with higher mortality through mechanisms that do not involve disability; they may 
behave as confounding factors. On the other hand, disability itself can increase the risk of 
certain conditions that could increase the risk of death, as mentioned in the introduction. 
Therefore, they could be considered mediators in the causal pathway from disability to 
mortality and should not be controlled for. We believe that greater part of the effect of 
disability health determinants on mortality is mediated by disability itself and a smaller part 
leads to death by paths that do not include disability. 
The analysis appears to reveal some systematic patterns. With the SRR being relatively 
invariant across sexes and higher at ages <65 years, it would appear that disability-related 
causes of death in the adult population were different than the most notable causes of 
disability among older people, i.e., dementia, stroke and depression. The tenfold SRR increase 
we found for severity when the latter was measured with our ICF score might indicate a role 
for activity limitations as risk-of-death determinants; our ICF score was mainly based on ICF 
activities and did not include visual and auditory impairments. The interplay between activity 
limitations and medical care has yet to be mapped as a crucial part of coordinating health and 
social services, which is frequently mentioned as a prominent but relatively little-known field 
of primary care. Understanding the relevance of specific activity limitations for determining 
risk of death when interacting with environmental (living alone, institutionalized, homebound, 
etc.) or personal (literacy) factors may constitute grounds for increased surveillance of non-
assisted disability persons, as has been proposed for primary care.24 In addition, large-scale 
epidemiological research could identify limitations in mobility, domestic activities or self-care 
associated with risk of death, as well as their potential underlying pathophysiological 
mechanisms. 
Some other considerations are worth mentioning. First, there was no information on mortality 
for 20% of the sample. However, we believe that the expected biasing impact on the estimates 
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will be small, mainly because these missing data were due to problems in the identification of 
subjects, and thus we can reasonably assume that they are randomly distributed. Second, we 
were unable to make the adjustment more comprehensive, and our estimates may 
consequently suffer from residual confounding. However, we do not expect this problem to be 
quantitatively important, when considered in comparison with the estimates found in similar 
studies with adjustment for health variables. In addition, we found that the mortality rate 
increased in the disability group for almost every cause of death. Third, individuals’ disability 
status was self-reported, and this can be a source of both over- and under-reporting. However, 
it is expected that this potential misclassification would have diluted the strength of the 
estimations. Finally, we could not include the institutionalized population. Neglecting the 
institutionalized severely disabled, 1/5 of the overall group24 may have led to an 
underestimation of SRD and the attributable fraction. 
Conclusion 
Risk of death is clearly higher in people with disability, with some causes of death showing an 
especially high risk, like neurological diseases and diabetes mellitus. In absolute terms, the 
number of deaths attributable to disability might well be very high. The population with 
disability must receive adequate preventive measures and health promotion initiatives to both 
improve survival and offer better quality of life. 
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Table 1. Baseline characteristics of study population aged 18 or over a 
 All Disability No disability 
Total, n (%) 162,381 (100) 18,600 (11) 143,781 (89) 
Age y, mean (SD) 48 (18) 66 (18) 45 (17) 
Age group, y (%)    
18-39  39 9 42 
40-64 41 31 42 
65-74 11 20 10 
≥75 10 40 6 
Sex, women (%) 51  60 50 
Lives with partner (%) 65 54 66 
Educational level attained (%)    
Illiterate and less than primary 16 44 13 
Primary (6 to 12 years old) 25 30 25 
Secondary (12 to 16 years old) 14 10 15 
Pre-university (16 to 18) 22 09 23 
University (18 and more years old) 23 07 25 
a Unweighted counts and weighted percentages (sampling weights) 
 
Table 2. Mortality rates (per 1000 person-years), rate differences and rate ratios standardized to the 
baseline total population distribution of age, sex, living with a partner and education 
 SR disability SR no disability SRD SRR 
Total 20.03 (18.99-21.07) 8.47 (8.22-8.72) 11.56 (10.52-12.60) 2.37 (2.24-2.50) 
Women 17.04 (15.89-18.19) 7.19 (6.88-7.51) 9.85 (8.68-11.02) 2.37 (2.19-2.56) 
Men 23.27 (21.6-24.95) 9.78 (9.45-10.12) 13.49 (11.8-15.18) 2.38 (2.20-2.57) 
Age 18-39 y 3.00 (1.91-4.09) 0.45 (0.38-0.51) 2.55 (1.46-3.65) 6.72 (4.55-9.93) 
Age 40-64 y 13.23 (11.89-14.57) 3.90 (3.71-4.1) 9.33 (7.97-10.68) 3.39 (3.02-3.80) 
Age 65-74 y 40.44 (37.48-43.39) 17.51 (16.67-18.36) 22.92 (19.85-25.99) 2.31 (2.12-2.52) 
Age ≥75 y 120.86 (117.16-124.56) 57.78 (55.83-59.73) 63.08 (58.87-67.28) 2.09 (2.00-2.19) 
SR, Standardized Rate; SRD, Standardized Rate Difference; SRR, Standardized Rate Ratio. 
 
Table 3. Association of ICF disability severity with mortality 
Severity SR a SRD b SRR c 
No disability 8.49 (8.24-8.74) 0 (ref.) 1 (ref.) 
Mild disability 15.26 (14.3-16.23) 6.77 (5.81-7.74) 1.80 (1.68-1.92) 
Moderate disability 36.84 (32.8-40.88) 28.35 (24.31-32.38) 4.34 (3.88-4.85) 
Severe/complete disability 88.85 (68.81-108.9) 80.36 (60.31-100.40) 10.46 (8.33-13.14) 
a Standardized rate per 1000 person-years, with the baseline total population distribution of 
age, sex, living with a partner and education as standard. 
b Standardized rate difference. 




Table 4. Association of number of disabilities with mortality  
No of disabilities SR a SRD b SRR c 
0 8.49 (8.24-8.74) 0 (ref.) 1 (ref.) 
1-3  13.53 (12.43-14.63) 5.04 (3.94-6.14) 1.59 (1.47-1.73) 
4-9 19.20 (17.48-20.92) 10.71 (8.98-12.43) 2.26 (2.06-2.48) 
10-42 42.54 (38.37-46.72) 34.06 (29.88-38.23) 5.01 (4.53-5.54) 
a Standardized rate per 1000 person-years, with the baseline total population distribution of 
age, sex, living with a partner and education as standard. 
b Standardized rate difference. 
c Standardized rate ratio. 
 
 
Table 5. Association of disability with mortality by group of causes  
Group of causes SRD (95%CI) a SRR (95%CI) b 
Certain infectious and parasitic diseases 0.28 (0.14-0.42) 3.38 (2.27-5.01) 
Neoplasms 2.13 (1.65-2.61) 1.74 (1.57-1.92) 
Diseases of the blood and blood-forming organs and 
certain disorders involving the immune mechanism   
0.02 (−0.00-0.05) 1.75 (0.94-3.26) 
Endocrine, nutritional and metabolic diseases 0.45 (0.33-0.57) 3.08 (2.43-3.90) 
Mental and behavioral disorders 0.40 (0.28-0.53) 2.43 (1.91-3.07) 
Diseases of the nervous system 1.46 (1.13-1.79) 4.86 (3.93-6.01) 
Diseases of the circulatory system 3.24 (2.78-3.71) 2.32 (2.12-2.55) 
Diseases of the respiratory system 1.42 (1.17-1.66) 2.69 (2.35-3.07) 
Diseases of the digestive system 0.56 (0.38-0.73) 2.25 (1.84-2.75) 
Diseases of the skin and subcutaneous tissue    0.03 (0.00-0.05) 2.38 (1.22-4.64) 
Diseases of the musculoskeletal system and connective 
tissue    
0.20 (0.09-0.31) 3.45 (2.18-5.47) 
Diseases of the genitourinary system 0.51 (0.37-0.65) 3.10 (2.44-3.94) 
Congenital malformations, deformations and 
chromosomal abnormalities   
0.05 (0.01-0.10) 28.23 (5.86-135.96) 
Symptoms, signs and abnormal clinical and laboratory 
findings, not elsewhere classified 
0.32 (0.19-0.46) 2.73 (2.01-3.71) 
External causes 0.47 (0.26-0.69) 2.68 (1.98-3.65) 
a Standardized rate differences, per 1000 person-years, with the baseline total population 
distribution of age, sex, living with a partner and education as the standard. 





Forty-four activities used to screen on possible disability 
 
1. Vision 
1.1. Perceiving any image. 
1.2. Visual detail tasks. 
1.3. Overall visual tasks. 
1.4. Other vision problems. 
2. Hearing 
2.1. Receive any sound. 
2.2. Hearing loud sounds. 
2.3. Listen to the speech. 
3. Communication 
3.1. Produce spoken messages. 
3.2. Receive spoken messages. 
3.3. Communication of written messages. 
3.4. Communication of gesture messages, signals or symbols. 
3.5. Have a conversation (only problems of a cognitive nature or intellectual). 
3.6. Communication through communication devices and techniques. 
4. Learning and application of knowledge and development of tasks (only problems of a cognitive or 
intellectual nature) 
4.1. Intentional use of the senses (looking, listening ...). 
4.2. Basic learning (reading, writing, counting ...). 
4.3. Carry out simple tasks. 
4.4. Perform complex tasks. 
5. Mobility 
5.1. Change basic body postures. 
5.2. Maintain body position. 
5.3. Moving around the home. 
5.4. Moving outside the home. 
5.5. Getting around using means of transport as a passenger. 
5.6. Driving vehicles. 
5.7. Lifting and carrying objects. 
5.8. Move objects with the upper limbs. 
5.9. Fine use of the hand. 
6. Self-care 
6.1. Toilet hygiene. 
6.2. Care of body parts. 
6.3. Personal hygiene related to urination. 
6.4. Personal hygiene related to defecation. 
6.5. Personal hygiene related to menstruation. 
6.6. Dressing and undressing. 
6.7. Eating and drinking. 
6.8. Taking care of one's own health: complying with medical prescriptions. 
6.9. Taking care of one's own health: avoiding dangerous situations. 
7. Domestic life 
7.1. Acquisition of goods and services. 
7.2. Prepare meals. 
7.3. Carry out household chores. 
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8. Interactions and personal relationships 
8.1. Basic interpersonal interactions. 
8.2. Relate to strangers. 
8.3. Formal relationships. 
8.4. Informal social relations. 
8.5. Family relationships. 
8.6. Sentimental relationships. 
 
Supplementary Figure 1. Standardized Rate Ratios and 95% CI for increasing years of follow-
up. 
 
Time-dependent Standardized Rate Ratios (SRR) and 95% confidence intervals for the 
association of disability and death with the baseline age, sex, living with a partner and 












Supplementary Figure 2. Standardized Rate Differences per 1000 person-years and 95% CI for 
increasing years of follow-up. 
 
Time-dependent Standardized Rate Differences (SRD) per 1000 person-years and 95% 
confidence intervals for the association of disability and death with the baseline age, sex, living 













SR  b 
 
 




001. Intestinal infectious diseases 38 1.63 1.97 (0.90-4.28) 4.8 
002.Tuberculosis and its late effects 8 0.38 5.32 (1.03-27.46) 26.7 
004. Septicemia 143 6.57 2.67 (1.76-4.05) 2.3 
005. Viral hepatitis 21 0.82 5.30 (1.80-15.65) 8.7 
006. AIDS 18 1.35 5.54 (1.21-25.34) 20.9 
008. Rest of infectious and parasitic diseases 
and their late effects 
23 1.04 4.98 (1.58-15.65) 9.9 
009. Malignant tumor of the lip, oral cavity 
and pharynx 
116 6.98 1.66 (0.89-3.1) 3.5 
010. Malignant tumor of the esophagus 92 5.28 1.77 (0.80-3.90) 4.9 
011. Malignant neoplasm of stomach 296 17.60 1.27 (0.78-2.08) 2.7 
012. Malignant tumor of the colon 554 30.27 1.56 (1.19-2.06) 1.7 
013. Malignant neoplasm of rectum, 
rectosigmoid portion and anus 
157 10.41 1.15 (0.66-2.00) 3.0 
014. Malignant tumor of the liver and 
intrahepatic bile ducts 
221 14.94 1.25 (0.78-1.99) 2.6 
015. Malignant tumor of the pancreas 271 16.87 0.99 (0.58-1.69) 2.9 
016. Other digestive malignancies 132 7.16 1.84 (1.03-3.29) 3.2 
017. Malignant tumor of the larynx 73 2.86 7.39 (3.66-14.92) 4.1 
018. Malignant tumor of the trachea, bronchi 
and lung 
963 58.06 1.53 (1.22-1.91) 1.6 
019. Other malignant respiratory and 
intrathoracic tumors 
21 1.25 1.62 (0.47-5.62) 12.0 
020. Malignant tumors of the bone and 
articular cartilage 
4 0.10 7.08 (0.79-63.59) 80.5 
021. Malignant melanoma of the skin  41 2.24 0.41 (0.16-1.09) 6.8 
022. Other malignant tumors of the skin and 
soft tissues 
62 4.07 1.73 (0.57-5.23) 9.2 
023. Malignant tumor of the breast 278 13.17 2.77 (1.96-3.93) 2.0 
024. Malignant tumor of the cervix 27 1.68 1.58 (0.53-4.77) 9.0 
025. Malignant tumor of other parts of the 
uterus 
87 4.67 1.9 (1.07-3.39) 3.2 
026. Malignant tumor of the ovary 77 4.05 1.09 (0.59-2.02) 3.4 
027. Malignant tumors, other female genital 
organs 
15 0.41 6.76 (1.91-23.86) 12.5 
028. Malignant tumor of the prostate 292 14.78 2.01 (1.4-2.89) 2.1 
029. Malignant tumors of other male genital 
organs 
7 0.54 6.62 (0.78-56.52) 72.5 
030. Malignant tumor of the kidney, except 
renal pelvis 
99 5.85 1.30 (0.70-2.40) 3.4 
031. Malignant tumor of the bladder 195 11.54 1.78 (1.17-2.71) 2.3 
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032. Other malignant tumors of the urinary 
tract 
42 2.27 1.75 (0.71-4.28) 6.0 
033. Malignant tumor of the brain 140 7.79 3.23 (1.70-6.14) 3.6 
034. Other malignant neurological and 
endocrine tumors 
27 1.69 0.86 (0.23-3.22) 14.0 
035. Malignant tumor of ill-defined, 
secondary, and unspecified sites 
251 13.14 2.25 (1.48-3.42) 2.3 
036. Malignant tumors of the lymphatic 
tissue, hematopoietic organs and related 
tissues (except leukemia) 
190 11.20 1.96 (1.19-3.24) 2.7 
037. Leukemia 145 7.84 1.64 (0.86-3.13) 3.6 
039. Benign tumors 23 1.53 2.81 (0.93-8.44) 9.1 
040. Myelodysplastic syndrome 52 2.53 1.46 (0.65-3.32) 5.1 
041. Other tumors of uncertain or unknown 
behavior 
103 5.73 1.76 (1.00-3.09) 3.1 
042. Diseases of the blood and hematopoietic 
organs 
57 2.88 1.60 (0.85-3.04) 3.6 
043. Certain disorders affecting the 
mechanism of immunity 
8 0.39 2.82 (0.46-17.14) 37.3 
044. Diabetes mellitus 388 14.51 3.56 (2.71-4.68) 1.7 
045. Other endocrine, nutritional and 
metabolic diseases 
131 7.07 2.09 (1.29-3.38) 2.6 
046. Organic, senile and presenile mental 
disorders 
628 27.29 2.29 (1.83-2.86) 1.6 
049. Other mental and behavioral disorders 6 0.38 13.45 (1.18-153.43) 130.0 
051. Alzheimer's disease 577 24.20 2.76 (2.20-3.45) 1.6 
052. Other diseases of the nervous system 
and sense organs 
407 13.70 8.52 (6.20-11.7) 1.9 
053. Chronic rheumatic heart diseases 80 3.41 4.01 (1.55-10.33) 6.7 
054. Hypertensive diseases 418 20.89 2.25 (1.54-3.27) 2.1 
055. Acute myocardial infarction 772 39.03 1.96 (1.60-2.40) 1.5 
056. Other ischemic heart diseases 706 34.73 2.45 (1.94-3.08) 1.6 
057. Heart failure 741 34.09 2.29 (1.88-2.78) 1.5 
058. Other heart diseases 934 46.97 2.04 (1.70-2.45) 1.4 
059. Cerebrovascular diseases 1217 54.97 2.57 (2.15-3.08) 1.4 
060. Atherosclerosis 62 2.05 3.04 (1.60-5.77) 3.6 
061. Other diseases of blood vessels 175 9.12 2.86 (1.61-5.08) 3.2 
062. Influenza (flu) includes avian flu and 
influenza A 
12 0.90 2.89 (0.55-15.33) 27.9 
063. Pneumonia 344 16.42 2.86 (2.06-3.97) 1.9 
064. Chronic diseases of the lower respiratory 
tract 
648 29.62 2.56 (2.05-3.2) 1.6 
065. Asthma 52 2.38 3.67 (1.61-8.36) 5.2 
066. Respiratory failure4 78 3.92 2.45 (1.36-4.39) 3.2 
067. Other diseases of the respiratory system 734 30.74 2.66 (2.19-3.24) 1.5 
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068. Ulcer of stomach, duodenum and 
jejunum 
29 1.69 2.12 (0.74-6.11) 8.3 
069. Non-infectious enteritis and colitis 15 0.72 2.30 (0.71-7.48) 10.5 
070. Intestinal vascular disease 146 6.18 2.97 (1.88-4.71) 2.5 
071. Cirrhosis and other chronic liver diseases 190 9.71 2.53 (1.62-3.94) 2.4 
072. Other diseases of the digestive system 503 26.18 1.98 (1.52-2.59) 1.7 
073. Skin and subcutaneous tissue diseases 52 2.00 2.38 (1.22-4.64) 3.8 
074. Rheumatoid arthritis and osteoarthritis 25 0.52 9.69 (2.84-33.06) 11.6 
075. Osteoporosis and pathological fracture 104 5.62 2.13 (1.27-3.59) 2.8 
076. Other diseases of the musculoskeletal 
system and connective tissue 
52 2.05 5.48 (2.26-13.27) 5.9 
077. Diseases of the kidney and ureter 340 13.88 3.32 (2.49-4.44) 1.8 
078. Diseases of the male genital organs 10 0.41 1.79 (0.4-8.11) 20.3 
080. Other diseases of the genitourinary 
system 
199 9.92 2.91 (1.93-4.38) 2.3 
084. Congenital malformations of the 
circulatory system 
5 0.16 1.87 (0.25-13.96) 55.8 
085. Other congenital malformations, 
deformities and chromosomal abnormalities 
9 0.03 155.43 (29.14-828.9) 28.4 
086. Cardiac arrest, unassisted death and 
other unknown cause of mortality 
171 10.10 2.96 (1.86-4.69) 2.5 
087. Senility 87 3.08 2.34 (1.36-4.02) 3.0 
089. Rest of symptoms, signs and findings ... 
not classified elsewhere 
121 5.54 2.54 (1.60-4.03) 2.5 
090. Motor vehicle traffic accidents 80 5.00 0.80 (0.37-1.73) 4.7 
091. Other transport accidents 6 0.27 14.87 (1.66-133.21) 80.2 
092. Accidental falls 108 6.29 1.23 (0.67-2.26) 3.4 
093. Accidental drowning, submersion and 
suffocation 
89 4.41 3.68 (1.82-7.44) 4.1 
094. Accidents due to fire, smoke and hot 
substances 
8 0.58 2.50 (0.38-16.6) 43.7 
095. Accidental poisoning by psychotropic 
drugs and drugs of abuse 
16 0.54 3.19 (0.9-11.24) 12.5 
096. Other accidental poisonings 6 0.17 19.04 (3.59-100.9) 28.1 
097. Other accidents 77 3.12 4.09 (1.98-8.43) 4.3 
098. Suicide and self-inflicted injuries 126 6.75 2.80 (1.33-5.87) 4.4 
099. Assaults (homicide) 8 0.44 0.68 (0.08-5.67) 70.9 
101. Complications of medical and surgical 
care 
14 0.52 3.97 (1.2-13.14) 11.0 
a Some causes not included due to insufficient number of cases. 
b Standardized mortality rate per 100,000 person-years, for the reference group (non-
disability) with the baseline total population distribution of age, sex, living with a partner, and 
education as the standard. 
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c Standardized mortality ratios, with the baseline total population distribution of age, sex, 
living with a partner and education as the standard. 
 
d Statistical precision; the ratio of the upper to lower 95% confidence limits. 
